Three commitments
Membership
Membership comes with the community app to track efficiency with matched peers.
$79 / year
Cosmo app. iOS only.
Cosmo is a tracking app, not a medical application.
Baseline → comparison
Move from average answers toward a result interpreted in your own context.
$1,500–$2,500
Depending on devices and selected tests.
Three molecular time points are the minimum needed to estimate variability, not a diagnosis or a complete organ model.
New intervention research
Help create the first reference protocol for a new intervention or a new relevant population.
$3,500+
Invitation only. Final cost and duration depend on the protocol.
No payment before invitation, final protocol scope, eligibility review and required oversight.
The compounding effect
Belong
Contribute to community
Answers are based on aggregate evidence.
Understand
Interpret for yourself
Baselines make matching possible.
Discover
Create what is missing
New cohorts add reference protocols that later members can use.
Cosmo turns advice into a repeatable protocol, captures the input and outcome, then shows your result beside relevant peers.
Andrew Huberman
“Get morning sunlight.”
How much morning light does your sleep need?
Dawn timer + duration + estimated intensity, matched to total and deep sleep.
Bryan Johnson
“Don’t eat before bed.”
What is your optimal food cutoff?
Last-calorie log + bedtime interval, compared with sleep duration and depth.
Peter Attia
“Train Zone 2 + VO₂ max.”
What is your minimum effective dose?
HR-zone verification + weekly load, read against recovery and VO₂ trend.
David Sinclair
“Trigger longevity pathways.”
What moves your measurable biology?
Protocol log + labs + wearable changes, aligned on one personal timeline.
Research now forming by invitation inside the club.
Performance research
Measure which performance protocol changes your sleep, recovery and useful waking capacity—not the average participant’s.
Current protocol ↗Body composition research
Bimagrumab + GLP‑1 asks whether fat loss can be separated from lean-mass loss—the trade-off that makes it somaforming.
Phase 2 evidence ↗Repair research
BPC‑157, TB‑500, GHK‑Cu and KPV are culturally huge and clinically immature. Multiomics makes the unknown part measurable.
Evidence gap ↗Visible change research
Melanotan II makes the problem visible: pigmentation, appetite and sexual effects can move through the same intervention.
Early human study ↗Invitation only. Final eligibility, intervention, measurements and oversight depend on the approved protocol.
Who is building this
Nutrition · Decision systems
100%FOOD, Planetarians founder. Systems with delayed ground truth researcher.
Biomarkers · modeling
Founder of Healome One and OpenAge AI; Nature Medicine co-author and OpenAge creator.
Molecular biology · data systems
Developer, molecular biologist and co-founder of Syntropy Health.
